Our study shows significantly low levels of adiponectin in psoriatics compared to controls and in diabetics with psoriasis compared with diabetics, confirming that the association between psoriasis and diabetes worsens glycemic control and increases cardiovascular risk. Here, ADIPOQ is linked to psoriasis.